KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Other financing activities (2016)

Globus Medical's Other financing activities history spans 6 years, with the latest figure at $116000.0 for Q4 2016.

  • For Q4 2016, Other financing activities rose 102.85% year-over-year to $116000.0; the TTM value through Dec 2016 reached $1.6 million, up 176.19%, while the annual FY2016 figure was $1.6 million, 176.19% up from the prior year.
  • Other financing activities reached $116000.0 in Q4 2016 per GMED's latest filing, down from $720000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.8 million in Q1 2014 to a low of -$4.1 million in Q4 2015.
  • Average Other financing activities over 5 years is $566250.0, with a median of $437000.0 recorded in 2014.
  • Peak YoY movement for Other financing activities: soared 8523.33% in 2012, then plummeted 1218.96% in 2015.
  • A 5-year view of Other financing activities shows it stood at $17000.0 in 2012, then soared by 1294.12% to $237000.0 in 2013, then soared by 53.59% to $364000.0 in 2014, then tumbled by 1218.96% to -$4.1 million in 2015, then soared by 102.85% to $116000.0 in 2016.
  • Per Business Quant, the three most recent readings for GMED's Other financing activities are $116000.0 (Q4 2016), $720000.0 (Q3 2016), and $254000.0 (Q2 2016).